{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T12:29:03Z","timestamp":1722947343571},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T00:00:00Z","timestamp":1397088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094858","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T21:13:37Z","timestamp":1397164417000},"page":"e94858","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hip Structural Parameters over 96 Weeks in HIV-Infected Adults Switching Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct00192634","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hila","family":"Haskelberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaki","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Robert","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Emery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"STEAL study investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,10]]},"reference":[{"volume":"26","key":"ref1","unstructured":"Hansen A-BE, Gerstoft J, Kronborg G, Larsen CS, Pedersen C, <etal>et al<\/etal>.. (2012) Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. AIDS <volume>26<\/volume>: : 285\u2013293 210.1097\/QAD.1090b1013e32834ed32838a32837."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"VA Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e32835192ae","article-title":"Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents","volume":"26","author":"R Bedimo","year":"2012","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"JA Kanis","year":"2002","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"D Marshall","year":"1996","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00198-003-1478-0","article-title":"Measuring the structural strength of bones with dual-energy X-ray absorptiometry: principles, technical limitations, and future possibilities","volume":"14","author":"T Beck","year":"2003","journal-title":"Osteoporosis International"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.bone.2007.03.007","article-title":"Hsa: Beyond bmd with dxa","volume":"41","author":"S Lou Bonnick","year":"2007","journal-title":"Bone"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/jbmr.5650090713","article-title":"Geometric structure of the femoral neck measured using dual-energy X-ray absorptiometry","volume":"9","author":"T Yoshikawa","year":"1994","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00256-012-1473-7","article-title":"Prediction of hip osteoporotic fractures from composite indices of femoral neck strength","volume":"42","author":"G-W Li","year":"2013","journal-title":"Skeletal radiology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00198-009-1056-1","article-title":"Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density?","volume":"21","author":"A LaCroix","year":"2010","journal-title":"Osteoporosis International"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00198-005-0019-4","article-title":"Femur strength index predicts hip fracture independent of bone density and hip axis length","volume":"17","author":"KGK Faulkner","year":"2006","journal-title":"Osteoporosis international"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s001980200071","article-title":"Hip fracture risk and proximal femur geometry from DXA scans","volume":"13","author":"C Bergot","year":"2002","journal-title":"Osteoporosis International"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1359\/jbmr.080802","article-title":"Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures","volume":"23","author":"S Kaptoge","year":"2008","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Tuck S, Rawlings D, Scane A, Pande I, Summers G, <etal>et al<\/etal>.. (2011) Femoral Neck Shaft Angle in Men with Fragility Fractures. Journal of Osteoporosis 2011.","DOI":"10.4061\/2011\/903726"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00198-011-1769-9","article-title":"Hip bone geometry in HIV\/HCV-co-infected men and healthy controls","volume":"23","author":"V Walker Harris","year":"2012","journal-title":"Osteoporosis International"},{"key":"ref16","first-page":"53","article-title":"Bone geometry and strength are adapted to muscle force in children and adolescents perinatally infected with HIV","volume":"13","author":"H Macdonald","year":"2013","journal-title":"Journal of musculoskeletal & neuronal interactions"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/644769","article-title":"Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial","volume":"49","author":"A Martin","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e38377","DOI":"10.1371\/journal.pone.0038377","article-title":"Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine","volume":"7","author":"H Haskelberg","year":"2012","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","article-title":"Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202","volume":"203","author":"GA McComsey","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/jc.2008-1807","article-title":"Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis","volume":"94","author":"EM Lewiecki","year":"2009","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00198-008-0762-4","article-title":"DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass","volume":"20","author":"S Bonnick","year":"2009","journal-title":"Osteoporosis international"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00223-011-9566-1","article-title":"Femoral Neck Bone Strength Estimated by Hip Structural Analysis (HSA) in Swedish Caucasians Aged 6\u201390 Years","volume":"90","author":"G Alwis","year":"2012","journal-title":"Calcified Tissue International"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"LC Hofbauer","year":"2004","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2007-2492","article-title":"Increased Plasma Osteoprotegerin Concentrations Are Associated with Indices of Bone Strength of the Hip","volume":"93","author":"EJ Samelson","year":"2008","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1210\/jc.2010-2617","article-title":"Cortical Bone Status Is Associated with Serum Osteoprotegerin Concentration in Men: The STRAMBO Study","volume":"96","author":"P Szulc","year":"2011","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejim.2012.05.011","article-title":"Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: A peripheral quantitative computed tomography (pQCT) study","volume":"23","author":"A Gaudio","year":"2012","journal-title":"European Journal of Internal Medicine"},{"key":"ref27","unstructured":"Bloch M, Tong W, Hoy J, Richardson R, Baker D, <etal>et al<\/etal>.. (2012) Improved Low Bone Mineral Density and Bone Turnover Markers with Switch from Tenofovir to Raltegravir in Virologically Suppressed HIV-1+ Adults at 48 Weeks: The TROP Study. Conference of Retrovirus and Opportunistic Infection. Washington."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study","volume":"51","author":"HJ Stellbrink","year":"2010","journal-title":"Clinical Infectious Diseases"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:23:52Z","timestamp":1540340632000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094858"}},"subtitle":[],"editor":[{"given":"Yi-Hsiang","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,10]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094858","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2014,4,10]]}}}